A carregar...

Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study

Randomized controlled trials have reported a 4–5 times increased risk of heart failure (HF) in breast cancer patients receiving trastuzumab (Herceptin(®)) compared to patients who do not receive trastuzumab. However, data regarding the cardiac effects of trastuzumab on elderly patients treated in ge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tsai, H.-T., Isaacs, C., Fu, A. Z., Warren, J. L., Freedman, A. N., Barac, A., Huang, C.-Y., Potosky, A. L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4133778/
https://ncbi.nlm.nih.gov/pubmed/24469642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2836-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!